查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
持续血糖监测系统 (CGM):各种技术、全球市场
市场调查报告书
商品编码
1172503

持续血糖监测系统 (CGM):各种技术、全球市场

Continuous Glucose Monitoring (CGM): Technologies and Global Markets
出版日期: | 出版商: BCC Research | 英文 123 Pages | 订单完成后即时交付

价格

全球持续血糖监测系统 (CGM) 的市场规模，预计从2022年的207亿美元，2027年成长到327亿美元，从2022年到2027年的年复合成长率为9.5％。

SMBG设备的部门，预计从2022年的100亿美元，2027年成长到147亿美元，从2022年到2027年的年复合成长率为7.9％。还有智慧型帮浦及笔的部门，预计从2022年的34亿美元，2027年成长到58亿美元，年复合成长率为11.4％。

本报告提供全球持续血糖监测系统 (CGM) 的市场调查，市场及技术的背景，市场成长的各种影响因素分析，市场规模的变化、预测，各种区分、各地区/主要国家的详细分析，专利趋势，竞争环境，主要企业简介等彙整资讯。

目录

第1章 简介

第2章 摘要、亮点

第3章 市场及技术的背景

  • 糖尿病
    • 糖尿病的类型
    • 糖尿病的诊断
    • 糖尿病的盛行率与全球经济负担
    • 糖尿病的治疗
    • 糖尿病的葡萄糖监测的重要性
    • SMBG设备
    • 非侵入性血糖监测系统
    • 持续血糖监测系统 (CGM)
    • CGM技术的提高的措施

第4章 市场明细:各技术类型

  • 持续血糖监测系统 (CGM) 设备的全球市场
  • 全球CGM市场
  • 全球智慧胰岛素帮浦及笔市场
  • 全球SMBG仪表及试验带市场

第5章 市场明细:各终端用户

  • CGM市场:各终端用户
  • 家用CGM市场
  • 医院、诊疗所
  • 其他

第6章 CGM市场:各糖尿病类型

  • 糖尿病各类型的CGM市场
  • 第一型糖尿病
  • 第二型糖尿病
  • 妊娠糖尿病
  • 其他

第7章 CGM市场:各用户年龄

  • 各用户年龄CGM市场
  • 儿童
  • 青少年世代
  • 青年人
  • 中年人
  • 老年人

第8章 市场明细:各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第9章 专利检讨

第10章 竞争情形

  • 市场占有率分析

第11章 COVID-19对CGM市场的影响

第12章 市场机会分析

第13章 企业简介

  • 主要企业
  • ABBOTT LABORATORIES
  • BETA BIONICS, INC.
  • BIGFOOT BIOMEDICAL
  • DEXCOM INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • INSULET CORP.
  • LIFESCAN IP HOLDINGS, LLC
  • MEDTRONIC PLC
  • NOVO NORDISK A/S
  • PKVITALITY
  • SANOFI S.A.
  • SENSEONICS HOLDINGS INC.
  • TANDEM DIABETES CARE
  • YPSOMED AG
  • 其他企业
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • EMPERRA GMBH E-HEALTH TECHNOLOGIES
  • GLUCOTRACK, INC.
  • INTUITY MEDICAL INC.
  • NEMAURA MEDICAL INC.
  • NOVIOSENSE BV
  • QLIBRIUM
  • SINOCARE INC.
Product Code: HLC102D

Highlights:

The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.

SMBG equipment segment of the global CGM market should reach $10 billion by 2022 and $14.7 billion by 2027, with a CAGR of 7.9% during the forecast period of 2022-2027.

Smart pumps and pens segment of the global CGM market should reach $3.4 billion by 2022 and $5.8 billion by 2027, with a CAGR of 11.4% during the forecast period of 2022-2027.

Report Scope:

The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.

Report Includes:

  • 27 data tables and 28 additional tables
  • A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies
  • Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments
  • Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region
  • Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.
  • Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
  • Review of the key patent grants and patent applications within select CGM technologies
  • Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.

Table of Contents

  • 1.1 Chapter 1 Introduction
  • 1.2 Study Goals and Objectives
  • 1.3 Reasons for Doing This Study
  • 1.4 Scope of Report
  • 1.5 What's New in This Update?
  • 1.6 Information Sources
  • 1.7 Research Methodology
  • 1.8 Geographic Breakdown
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

  • 2.1 Highlights of the Market for CGM Devices

Chapter 3 Market and Technology Background

  • 3.1 Diabetes
    • 3.1.1 Types of Diabetes Mellitus
    • 3.1.2 Diabetes Diagnosis
    • 3.1.3 Diabetes Prevalence and Global Economic Burden
    • 3.1.4 Treatment of Diabetes
    • 3.1.5 Importance of Glucose Monitoring in Diabetes
    • 3.1.6 SMBG Devices
    • 3.1.7 Noninvasive Blood Glucose Monitoring
    • 3.1.8 Continuous Glucose Monitoring (CGM)
    • 3.1.9 Working to Improve CGM Technology

Chapter 4 Market Breakdown by Technology Type

  • 4.1 Global Market for Continuous Glucose Monitoring (CGM) Devices
  • 4.2 Global CGM Markets
  • 4.3 Global Smart Insulin Pumps and Pens Markets
  • 4.4 Global SMBG Meters and Test Strips Markets

Chapter 5 Market Breakdown by End-User Settings

  • 5.1 CGM Market, by End-User Settings
  • 5.2 CGM Market for Home Use
  • 5.3 Hospital and Clinics
  • 5.4 Others

Chapter 6 CGM Market by Type of Diabetes

  • 6.1 CGM Markets, by Type of Diabetes
  • 6.2 Type 1 Diabetes
  • 6.3 Type 2 Diabetes
  • 6.4 Gestational Diabetes
  • 6.5 Others

Chapter 7 CGM Markets, by User's Age

  • 7.1 CGM Markets, by User's Age
  • 7.2 Children
  • 7.3 Teenagers
  • 7.4 Youth
  • 7.5 Middle-Aged
  • 7.6 Aged

Chapter 8 Market Breakdown by Region

  • 8.1 North America
    • 8.1.1 U.S
    • 8.1.2 Canada
  • 8.2 Europe
    • 8.2.1 Germany
    • 8.2.2 The UK
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Rest of Europe
  • 8.3 Asia-Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 South Korea
    • 8.3.4 Rest of Asia-Pacific
  • 8.4 Rest of the World

Chapter 9 Patent Review

  • 9.1 Patent Review

Chapter 10 Competitive Landscape

  • 10.1 Market Share Analysis

Chapter 11 COVID-19 Impact on the CGM Market

  • 11.1 COVID-19 Impact on the CGM Market

Chapter 12 Analysis of the Market Opportunities

Chapter 13 Company Profiles

  • 13.1 Major Companies
  • ABBOTT LABORATORIES
  • BETA BIONICS, INC.
  • BIGFOOT BIOMEDICAL
  • DEXCOM INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • INSULET CORP.
  • LIFESCAN IP HOLDINGS, LLC
  • MEDTRONIC PLC
  • NOVO NORDISK A/S
  • PKVITALITY
  • SANOFI S.A.
  • SENSEONICS HOLDINGS INC.
  • TANDEM DIABETES CARE
  • YPSOMED AG
  • 13.2 Other Companies
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • EMPERRA GMBH E-HEALTH TECHNOLOGIES
  • GLUCOTRACK, INC.
  • INTUITY MEDICAL INC.
  • NEMAURA MEDICAL INC.
  • NOVIOSENSE BV
  • QLIBRIUM
  • SINOCARE INC.

List of Tables

  • Summary Table : Global Market for CGM, by Technology Type, Through 2027
  • Table 1 : Top 15 Countries with High Prevalence of Diabetes, 2021
  • Table 2 : Selected Companies Developing Noninvasive Blood Glucose Monitoring Devices
  • Table 3 : The Key Approved CGM Devices
  • Table 4 : Global Market for CGM Devices, by Type, Through 2027
  • Table 5 : Global Market for CGM, by Region, Through 2027
  • Table 6 : Global Market for CGM Transmitters and Receivers, and Sensors, Through 2027
  • Table 7 : Global Market for Smart Insulin Pumps and Pens, by Region, Through 2027
  • Table 8 : Global Market for Smart Insulin Pumps and Pens, by Type, Through 2027
  • Table 9 : Global Market for SMBG Equipment, by Region, Through 2027
  • Table 10 : Global Market for SMBG Meters and Test Strips, by Type, Through 2027
  • Table 11 : Global Market for CGM, by End-User Settings, Through 2027
  • Table 12 : Global Market for CGM in Home Use, by Region, Through 2027
  • Table 13 : Global Market for CGM in Hospitals and Clinics, by Region, Through 2027
  • Table 14 : Global Market for CGM in Other Settings, by Region, Through 2027
  • Table 15 : Global Market for CGM, by Diabetes Type, Through 2027
  • Table 16 : Global Market for CGM in Type 1 Diabetes, by Region, Through 2027
  • Table 17 : Global Market for CGM in Type 2 Diabetes, by Region, Through 2027
  • Table 18 : Global Market for CGM in Gestational Diabetes, by Region, Through 2027
  • Table 19 : Global Market for CGM in Other Conditions, by Region, Through 2027
  • Table 20 : Global Market for CGM, by User's Age, Through 2027
  • Table 21 : Global Market for CGM in Children, by Region, Through 2027
  • Table 22 : Global Market for CGM in Teenagers, by Region, Through 2027
  • Table 23 : Global Market for CGM in Youth, by Region, Through 2027
  • Table 24 : Global Market for CGM in Middle-Aged, by Region, Through 2027
  • Table 25 : Global Market for CGM in Aged, by Region, Through 2027
  • Table 26 : Global Market for CGM, by Region, Through 2027
  • Table 27 : North American Market for CGM, Through 2027
  • Table 28 : European Market for CGM, by Country, Through 2027
  • Table 29 : Asia-Pacific Market for CGM, by Country, Through 2027
  • Table 30 : Patent Record and Key Patent Areas of Applicants, 2019-2022
  • Table 31 : Abbott Laboratories.: CGM Products
  • Table 32 : Abbott Laboratories: Key Development
  • Table 33 : Beta Bionics, Inc.: Key Developments
  • Table 34 : Dexcom Inc.: CGM Products
  • Table 35 : Dexcom Inc.: Key Development
  • Table 36 : F. Hoffmann-La Roche: Product Portfolio
  • Table 37 : F. Hoffmann-La Roche: Key Developments
  • Table 38 : Insulet Corp.: CGM Products
  • Table 39 : Insulet Corp.: Key Developments
  • Table 40 : Lifescan IP Holdings, LLC.: CGM Products
  • Table 41 : Lifescan IP Holdings, LLC: Key Developments
  • Table 42 : Medtronic PLC.: CGM Products
  • Table 43 : Medtronic PLC: Key Developments
  • Table 44 : Novo Nordisk: Products Portfolio
  • Table 45 : Novo Nordisk: Key Developments
  • Table 46 : PKvitality: Key Developments
  • Table 47 : Sanofi S.A.: Products Portfolio
  • Table 48 : Sanofi S.A.: Key Developments
  • Table 49 : Senseonics Holdings, Inc.: Products Portfolio
  • Table 50 : Senseonics Holdings, Inc.: Key Developments
  • Table 51 : Tandem Diabetes Care: CGM Products
  • Table 52 : Tandem Diabetes Care: Key Developments
  • Table 53 : Ypsomed AG: CGM Products
  • Table 54 : Ypsomed AG: Key Developments

List of Figures

  • Summary Figure : Global Market for CGM, by Technology Type, 2019-2027
  • Figure 1 : Global Diabetic Population, by Region, 2021
  • Figure 2 : Global Market Shares of CGM Devices, by Type, 2021
  • Figure 3 : Global Market for CGM, by Region, 2019-2027
  • Figure 4 : Global Market Shares of CGM Transmitters and Receivers, and Sensors, by Type, 2021
  • Figure 5 : Advantages of Connected Insulin Delivery Systems
  • Figure 6 : Global Market for Smart Insulin Pumps and Pens, by Region, 2019-2027
  • Figure 7 : Global Market Shares of Smart Insulin Pumps and Pens, by Type, 2021
  • Figure 8 : Global Market for SMBG Equipment, by Region, 2019-2027
  • Figure 9 : Global Market Shares of SMBG Meters and Test Strips, by Type, 2021
  • Figure 10 : Global Market Shares of CGM, by End-User Settings, 2021
  • Figure 11 : Global Market for CGM in Home Use, by Region, 2019-2027
  • Figure 12 : Global Market for CGM in Hospitals and Clinics, by Region, 2019-2027
  • Figure 13 : Global Market for CGM in Other Settings, by Region, 2019-2027
  • Figure 14 : Global Market Shares of CGM, by Diabetes Type, 2021
  • Figure 15 : Global Market for CGM, by Diabetes Type, 2019-2027
  • Figure 16 : Global Market for CGM in Type 1 Diabetes, 2019-2027
  • Figure 17 : Global Market for CGM in Type 2 Diabetes, 2019-2027
  • Figure 18 : Global Market for CGM in Gestational Diabetes, 2019-2027
  • Figure 19 : Global Market for CGM in Other Conditions, 2019-2027
  • Figure 20 : Various Barriers to CGMs Usage, by User's Age
  • Figure 21 : Global Market Shares of CGM, by User's Age, 2021
  • Figure 22 : Global Market for CGM in Children, 2019-2027
  • Figure 23 : Global Market for CGM in Teenagers, 2019-2027
  • Figure 24 : Global Market for CGM in Youth, 2019-2027
  • Figure 25 : Global Market for CGM in Middle-Aged, 2019-2027
  • Figure 26 : Global Market for CGM in Aged, 2019-2027
  • Figure 27 : Snapshot of Global Market for Continuous Glucose Monitoring, by Region
  • Figure 28 : Global Market Shares of CGM, by Region, 2021
  • Figure 29 : U.S. Diabetes Prevalence Statistics
  • Figure 30 : U.S. Market for CGM, 2019-2027
  • Figure 31 : Canadian Market for CGM, 2019-2027
  • Figure 32 : European Market Shares of CGM, by Country, 2021
  • Figure 33 : German Market for CGM, 2019-2027
  • Figure 34 : The UK Market for CGM, 2019-2027
  • Figure 35 : French Market for CGM, 2019-2027
  • Figure 36 : Italy Market for CGM, 2019-2027
  • Figure 37 : Rest of European Market for CGM, 2019-2027
  • Figure 38 : Asia-Pacific Market Shares of CGM, by Country, 2021
  • Figure 39 : Chinese Market for CGM, 2019-2027
  • Figure 40 : Japanese Market for CGM, 2019-2027
  • Figure 41 : South Korean Market for CGM, 2019-2027
  • Figure 42 : Rest of Asia-Pacific Market for CGM, 2019-2027
  • Figure 43 : Rest of the World Market for CGM, 2019-2027
  • Figure 44 : CGM Patent Filings, by Year, 2019-2022
  • Figure 45 : CGM Patent Filings, by Jurisdiction, 2019-2022
  • Figure 46 : Patent Filings Shares, by Applicants, 2019-2022
  • Figure 47 : Global Company Market Shares of CGM Manufacturers, 2021
  • Figure 48 : CGM Market Opportunity Analysis Overview
  • Figure 49 : Abbott Laboratories: Annual Revenue, 2019-2021
  • Figure 50 : Abbott Laboratories: Market Shares, by Business Segment, 2021
  • Figure 51 : Abbott Laboratories: Market Shares, by Region, 2021
  • Figure 52 : Dexcom Inc.: Annual Revenue, 2019-2021
  • Figure 53 : Dexcom Inc.: Market Shares, by Region, 2021
  • Figure 54 : F. Hoffmann-La Roche: Annual Revenue, 2019-2021
  • Figure 55 : F. Hoffmann-La Roche: Revenue Share, by Division, 2021
  • Figure 56 : Insulet Corp.: Annual Revenue, 2020 and 2021
  • Figure 57 : Insulet Corp.: Market Shares of OmniPod, by Region, 2021
  • Figure 58 : Medtronic PLC: Annual Revenue, 2019-2021
  • Figure 59 : Medtronic PLC: Market Shares, by Region, 2021
  • Figure 60 : Medtronic PLC: Market Shares, by Business Segment, 2021
  • Figure 61 : Novo Nordisk: Annual Revenue, 2019-2021
  • Figure 62 : Novo Nordisk: Revenue Share, by Business Segment, 2021
  • Figure 63 : Sanofi S.A.: Annual Revenue, 2019-2021
  • Figure 64 : Sanofi S.A.: Revenue Share, by Business Unit, 2021
  • Figure 65 : Senseonics Holdings, Inc.: Annual Revenue, 2020 and 2021
  • Figure 66 : Tandem Diabetes Care: Annual Revenue, 2019-2021
  • Figure 67 : Tandem Diabetes Care: Market Shares, by Region, 2021
  • Figure 68 : Tandem Diabetes Care: Market Shares, by Business Segment, 2021
  • Figure 69 : Ypsomed AG: Annual Revenue, 2020 and 2021
  • Figure 70 : Ypsomed AG: Market Shares, by Region, 2021
  • Figure 71 : Ypsomed AG: Market Shares, by Business Segment, 2021